APPLICATION
ANDA078361
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-22
LATEST ACTION
2019-10-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DESLORATADINEDiscontinued
DESLORATADINE 5MG · TABLET · ORAL
Approval history
2019-10-22Labeling · Supplement 6 · standardAP
2017-10-20Labeling · Supplement 5 · standardAP
2011-12-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.